Home | About us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionContact Us   |  Subscribe   |  Advertise   |  Login  Page layout
Wide layoutNarrow layoutFull screen layout
Lung India Official publication of Indian Chest Society  
  Users Online: 82   Home Print this page  Email this page Small font size Default font size Increase font size
Year : 1990  |  Volume : 8  |  Issue : 1  |  Page : 7-10

Role Of Ipratropium Bromide And Salbutamol Inhalers In Bronchial Asthma - A Comparative Study

Correspondence Address:
S. D Purohit

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Patients of bronchial asthma were put on salbutamol, ipratropium bromide and salbutamol plus ipratropium bromide inhaler in a cross over manner to assess the relative efficacy of the drugs. Both salbutamol and ipratropium bromide inhalers were found to produce significant rise in airway functions i.e. FEV1, PEFR and FEF25-75% (p<0.005). The mean rise was higher in patients while they were on salbutamol as compared to ipratropium bromide (P<0.01). Addition of ipratropium bromide to salbutamol inhaler further enhanced the bronchodilator action of the latter drug (p<0.02). Adverse reactions were minimal and self-limiting. Majority of the patients preferred salbutamol inhaler as compared to ipratropium bromide.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded118    
    Comments [Add]    

Recommend this journal